ClinicalTrials.Veeva

Menu

"Bronchoscopic Argon Plasma Coagulation for Managing Endobronchial Carcinoid Lesions

A

Alexandria University

Status

Completed

Conditions

Endobronchial Carcinoid

Treatments

Procedure: bronchoscopic argon plasma coagulation

Study type

Interventional

Funder types

Other

Identifiers

NCT06757920
FOB - Endobronchial Carcinoid

Details and patient eligibility

About

A small tube will go through the respiratory tract and a non contact cauterization will be done to the inside tumor

Full description

fiberoptic bronchoscopy will go through the tracheobronchial tree and after localization of the tumor, argon plasma coagulation by initiation non contact electrocautery will be done to the tumor

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

1 - Cooperative patient with written informed consent. 2- Patients diagnosed with endobronchial carcinoid. 3- Patients fit for fiberoptic bronchoscopy. 4- Patients unwilling or unfit for surgery.

Exclusion criteria

1 -Poor karnofsky score. 2- Patients unwilling or unfit for bronchoscopy. 3- Extraluminal lesion. 4- Patients with pacemaker. 5- Forced expiratory volume 1 is less than one litre.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 1 patient group

fiberoptic bronchoscopy in one group
Active Comparator group
Description:
fiberoptic bronchoscopic argon plasma coagulation for palliation of endobronchial carc inoid
Treatment:
Procedure: bronchoscopic argon plasma coagulation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems